---
figid: PMC9626530__fphar-13-1024955-g002
figtitle: Therapeutic potential of triptolide and celastrol in neurological diseases
organisms:
- Mus musculus
- Rattus norvegicus
- mixed culture
- Adeno-associated virus
- Panax notoginseng
- Tripterygium wilfordii
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC9626530
filename: fphar-13-1024955-g002.jpg
figlink: /pmc/articles/PMC9626530/figure/F2/
number: F2
caption: Mechanisms of action of triptolide in neurological diseases. The mechanisms
  of action of triptolide in neurological diseases involves neuroinflammation, neurotrophic
  effects, and other neuroprotective effects. It attenuates neuroinflammation and
  regulate inflammation levels in microglia and neuron, as evidenced by increased
  expression of anti-inflammatory factors and decreased expression of pro-inflammatory
  factors. Signaling pathways such as NF-kB are involved in this regulation. In addition,
  current studies have reported neurotrophic effects of triptolide for neurological
  diseases. Triptolide increases the expression levels of NGF, synaptophysin, neuroligin-1,
  and BDNF mRNA, and it also inhibits astrogliosis and excessive glial scar, which
  is associated with the regulation of JAK2/STAT3 signaling pathway. Furthermore,
  triptolide can act directly on neurons and thus exert neuroprotective effects by
  affecting other signaling pathways such as autophagy and apoptosis.
papertitle: The therapeutic potential of triptolide and celastrol in neurological
  diseases.
reftext: Yueran Cui, et al. Front Pharmacol. 2022;13:1024955.
year: '2022'
doi: 10.3389/fphar.2022.1024955
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: neurological diseases | traditional Chinese medicine | triptolide | celastrol
  | neuroprotection | toxicity | derivatives
automl_pathway: 0.9648333
figid_alias: PMC9626530__F2
figtype: Figure
redirect_from: /figures/PMC9626530__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9626530__fphar-13-1024955-g002.html
  '@type': Dataset
  description: Mechanisms of action of triptolide in neurological diseases. The mechanisms
    of action of triptolide in neurological diseases involves neuroinflammation, neurotrophic
    effects, and other neuroprotective effects. It attenuates neuroinflammation and
    regulate inflammation levels in microglia and neuron, as evidenced by increased
    expression of anti-inflammatory factors and decreased expression of pro-inflammatory
    factors. Signaling pathways such as NF-kB are involved in this regulation. In
    addition, current studies have reported neurotrophic effects of triptolide for
    neurological diseases. Triptolide increases the expression levels of NGF, synaptophysin,
    neuroligin-1, and BDNF mRNA, and it also inhibits astrogliosis and excessive glial
    scar, which is associated with the regulation of JAK2/STAT3 signaling pathway.
    Furthermore, triptolide can act directly on neurons and thus exert neuroprotective
    effects by affecting other signaling pathways such as autophagy and apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bcl2
  - Hspa4
  - Hspa1b
  - Bace1
  - Cxcr2
  - Ephb1
  - Mtor
  - Akt1
  - Pik3cg
  - Wnt2
  - Il10
  - Il13
  - Tnf
  - Nfkb1
  - Casp6
  - Olah
  - Mapk14
  - Mir96
  - Bbc3
  - Mapk3
  - Ngf
  - Bdnf
  - Jak2
  - Ephb2
  - Mapk1
  - Mdk
  - Pik3r1
  - Mch
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Inpp5d
  - Ikbkb
  - Wasf1
  - Jun
  - BCL2
  - IL6
  - HSPA1A
  - HSPA4
  - BACE1
  - CXCR2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - IL10
  - IL13
  - TNF
  - NFKB1
  - CASP6
  - MCHR2
  - PMCH
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - INPP5D
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MIR96
  - BBC3
  - NGF
  - BDNF
  - BDNF-AS
  - RPS4X
  - AGER
  - CD14
  - CD163
  - CD163L1
  - CD207
  - CD209
  - CD36
  - CD68
  - CLEC7A
  - COLEC12
  - CXCL16
  - LY75
  - MARCO
  - MEGF10
  - MRC1
  - MSR1
  - OLR1
  - SCARA3
  - SCARA5
  - SCARB1
  - SCARB2
  - SCARF1
  - SCARF2
  - SSC4D
  - SSC5D
  - STAB1
  - STAB2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - JAK2
  - chmp2a
  - hsf1
  - hsp70.3
  - hspa8l
  - hsp70l
  - hsp70.1
  - bace1
  - cxcr2
  - mtor
  - il10
  - il13
  - tnfb
  - mapk14a
  - mir9-6
  - dre-mir-96
  - mapk3
  - ngfb
  - bdnf
  - jak2b
  - Debcl
  - Hsf
  - Hsc70-3
  - Hsc70-1
  - Hsc70-4
  - Hsp70Ab
  - Hsp70Ba
  - Hsp70Aa
  - Hsp70Bb
  - Hsp70Bc
  - Hsp70Bbb
  - Bace
  - Erk7
  - rl
  - Dsor1
  - Mtk
  - Tor
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Wnt5
  - Wnt4
  - wg
  - egr
  - Dif
  - dl
  - Rel
  - mch
  - MKP-4
  - p38b
  - lic
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - IKKepsilon
  - key
  - IKKbeta
  - sgg
  - SCAR
  - AP-1gamma
  - Jra
  - kay
  - triptolide
  - PGE2
  - synaptophysin
---
